Navigation Links
Savara Pharmaceuticals' AeroVanc Granted U.S. Orphan Drug Designation for the Treatment of MRSA Lung Infection in Cystic Fibrosis Patients
Date:11/13/2012

AUSTIN, Texas, Nov. 13, 2012 /PRNewswire/ -- Savara Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug status to AeroVanc™ (vancomycin hydrochloride inhalation powder) for the treatment of pulmonary methicillin-resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis (CF) patients. Orphan drug designation qualifies a company for several benefits, including the potential for market exclusivity, development grants, and for certain tax credits.

AeroVanc is the first inhaled antibiotic being developed to address the growing population of MRSA-infected CF patients. Savara is currently preparing for its Phase IIa clinical study of AeroVanc's efficacy, to be carried out in 20 CF centers in the United States. In Phase I studies of AeroVanc in healthy volunteers and CF patients, AeroVanc was well tolerated and demonstrated an excellent pharmacokinetic profile.

"AeroVanc is a much needed addition to the current treatment options for MRSA infected CF patients," said Michael Konstan, M.D., Chairman, Department of Pediatrics, and Director of the Cystic Fibrosis Center at Rainbow Babies and Children's Hospital and Case Western Reserve University. "In the absence of an FDA approved inhaled antibiotic therapy directed at MRSA, CF clinicians are increasingly prescribing off-label nebulization of the intravenous formulation of vancomycin. This therapy is generally well tolerated, has high antibacterial activity against MRSA, and patients have a good clinical response."

"Orphan drug designation in combination with our intellectual property provides strong market exclusivity potential for AeroVanc," said Robert Neville, Chief Executive Officer of Savara Pharmaceuticals. "We hope to provide similar benefits to MRSA infected patients that tobramycin provides for the treatment of Pseudomonas aeruginosa infections. The response from the cystic fibrosis community has
'/>"/>

SOURCE Savara Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
2. Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
3. Frost & Sullivan: Lack of Proper Price Regulation for Pharmaceuticals
4. Jazz Pharmaceuticals Announces Participation In Three Investor Conferences In November
5. Achillion Pharmaceuticals, Inc. Hosts the HCV Connection Media Briefing at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
6. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
7. Jazz Pharmaceuticals Announces Third Quarter 2012 Results
8. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
9. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Isis Pharmaceuticals To Present At The 2012 Credit Suisse Healthcare Conference
11. Savient Pharmaceuticals Reports Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015 RoundTable Healthcare Partners ("RoundTable"), ... the healthcare industry, announced today that it has ... the "Company"). Founded in 1969 in ... a manufacturer of paper-based barrier products. Through a ... has expanded its product offering to include a ...
(Date:7/6/2015)... DUBLIN , June 29, 2015 ... the addition of the "Pharmaceutical Packaging Market in ... The pharmaceutical packaging market in North ... 5.31% over the period 2014-2019. International ... bodies on drug manufacturers, which in turn fuels adoption ...
(Date:7/6/2015)... -- Hologic, Inc. (NASDAQ: HOLX ) announced today ... for the third quarter of fiscal 2015 on Wednesday, ... with the release, management will host a conference call ... Interested participants may listen to the call by dialing ... or 719-325-4804 (for international callers) and referencing access code ...
Breaking Medicine Technology:RoundTable Healthcare Partners Acquires TIDI Products 2RoundTable Healthcare Partners Acquires TIDI Products 3North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2
... study appearing in the March,22 New England Journal ... Healths National Institute of Arthritis and,Musculoskeletal and Skin ... gene and the inflammatory skin,condition vitiligo, as well ... is a chronic condition in which melanocytes (the ...
... and Potentially Suited for Once,Daily Administration, PRINCETON, ... an innovator in the discovery and development ... results,from the initial Phase 1 clinical trial ... for the treatment of hypertension,and diabetic nephropathy. ...
Cached Medicine Technology:Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases 2Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases 3Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 2Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 3Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 4Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 5
(Date:7/6/2015)... ... July 06, 2015 , ... Shortly after opening her second practice in Signal ... doctors working on a lien basis. Dr. Lim had previously worked with Dr. ... two Cambodian refugees, Dr. Lim suffered with back pain herself throughout high school. ...
(Date:7/6/2015)... UK (PRWEB) , ... July 06, 2015 , ... The ... billion in 2014. It is expected to grow at a CAGR of over 3.2 ... 2021. , The growth is likely to be mainly spurred by an anticipated launch ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... southern California, has partnered with Woodbridge Walk-In Urgent Care to offer on-site health ... other serious medical conditions. Screenings are affordable and accurate and run about an ...
(Date:7/6/2015)... ... July 06, 2015 , ... With a ... once again teamed up with Family Emergency Shelter Coalition (FESCO) and announced a ... FESCO was created especially to provide emergency services and support for homeless families, ...
(Date:7/6/2015)... ... July 06, 2015 , ... The School of ... to support a three-year effort to reduce rates of diabetes and cardiovascular disease ... partnership with the Morehouse School of Medicine’s Prevention Research Center and the Satcher ...
Breaking Medicine News(10 mins):Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2
... 15, CDC says , , WEDNESDAY, May 6 (HealthDay News) -- ... mild, those who are hospitalized due to more severe disease ... In fact, the median age of hospitalized individuals with swine ... seasonal flu, U.S. Centers for Disease Control and Prevention acting ...
... practices to prevent the spread of flu- proper hand washing, visiting ... , WASHINGTON, May 6 /PRNewsiwre-USNewswire/ -- ... outbreak, but more than half of the people are paying extra ... themselves from the virus, according to a new poll by the ...
... LAS VEGAS, May 6 Results of the Clopidogrel Medco ... the anti-clotting benefits of clopidogrel (Plavix) may be reduced when ... inhibitors (PPIs). In the study, patients taking clopidogrel and ... 50% increase in the ...
... 6 Litigation surrounding health and damage claims relating ... conference to be held in New Orleans. The ... Baron & Budd, according to HB Litigation Conferences LLC, ... the subject, one for insurance attorneys and in-house counsel, ...
... and memory loss motivates the birth of a new ... 6 In Chicagoland alone, more than ... memory loss conditions while 320,894 are at high risk ... households don,t have at least one caregiver with the ...
... tied to surgery, anesthesia, experts note, , , WEDNESDAY, May ... people with Alzheimer,s who are hospitalized might accelerate their ... that people with Alzheimer,s who had an episode of ... cognitive decline that was three times faster than that ...
Cached Medicine News:Health News:Younger Age of Severe Swine Flu Cases Worries Experts 2Health News:Younger Age of Severe Swine Flu Cases Worries Experts 3Health News:Younger Age of Severe Swine Flu Cases Worries Experts 4Health News:Younger Age of Severe Swine Flu Cases Worries Experts 5Health News:Younger Age of Severe Swine Flu Cases Worries Experts 6Health News:Younger Age of Severe Swine Flu Cases Worries Experts 7Health News:Younger Age of Severe Swine Flu Cases Worries Experts 8Health News:Younger Age of Severe Swine Flu Cases Worries Experts 9Health News:Younger Age of Severe Swine Flu Cases Worries Experts 10Health News:Younger Age of Severe Swine Flu Cases Worries Experts 11Health News:Younger Age of Severe Swine Flu Cases Worries Experts 12Health News:Younger Age of Severe Swine Flu Cases Worries Experts 13Health News:Younger Age of Severe Swine Flu Cases Worries Experts 14Health News:Polls Show Americans Concerned About Swine Flu, Taking Actions to Protect Themselves 2Health News:Polls Show Americans Concerned About Swine Flu, Taking Actions to Protect Themselves 3Health News:SCAI Statement on 'A National Study of the Effect of Individual Proton Pump Inhibitors on Cardiovascular Outcomes in Patients Treated with Clopidogrel Following Coronary Stenting: The Clopidogrel Medco Outcomes Study' 2Health News:HB Litigation Conferences Announces Conference and Two Teleconferences on Chinese Drywall Litigation and Insurance 2Health News:Latinos in Chicago and Suburbs Face Alarming Numbers of Cases of Alzheimer's Disease While Thousands More are at Risk of Being Diagnosed 2Health News:Latinos in Chicago and Suburbs Face Alarming Numbers of Cases of Alzheimer's Disease While Thousands More are at Risk of Being Diagnosed 3Health News:Delirium Episodes Could Hasten Alzheimer's-Linked Decline 2Health News:Delirium Episodes Could Hasten Alzheimer's-Linked Decline 3
ELISA Microplate Washer, Manual...
Designed to meet the demands of today's laboratories for RO water....
... 8000 L/day of Type III Laboratory-grade Water, ... produce up to 8000 L/day of Type ... One Complete Purification and Control Unit, RiOs ... system, providing total control of all parameters ...
... Produce Up to 8000 L/day of Type ... are designed to produce up to 8000 ... potable tap feedwater., One Complete Purification and ... into a centralized system, providing total control ...
Medicine Products: